For a long time, drug makers have been the most hated industry in America. Companies are blamed for gouging prices on lifesaving drugs and enriching themselves through the opioid crisis, among other sins.

Now, with pharmaceutical companies racing to find vaccines to end the coronavirus pandemic, the industry is hoping to redeem itself in the public’s mind.

The primary goal, of course, is to rescue the world from the grips of a vicious virus. But a big fringe benefit is to get public credit — and to use an improved image to fend off government efforts to more heavily regulate the industry.

Consider Johnson & Johnson, one of the world’s largest health care companies.

In recent years, its reputation has been battered by accusations that products like its artificial hips and talcum powder have harmed customers. In 2019, an Oklahoma judge ordered the company to pay $572 million for contributing to the opioid epidemic.

More in category

3 Great Stocks for Low-Risk Investors
October 20, 2020The Motley Fool
3 Great Stocks for Low-Risk Investors
Moderna CEO: Coronavirus vaccine approval may come by December
October 20, 2020FOX Business
Moderna CEO: Coronavirus vaccine approval may come by December
Some want Facebook, Twitter to remove 'trending' sections ahead of election
October 20, 2020FOX Business
Some want Facebook, Twitter to remove 'trending' sections ahead of election
Coronavirus relief deadline looms, but odds of deal before election are slim
October 20, 2020FOX Business
Coronavirus relief deadline looms, but odds of deal before election are slim
Beware of Investing in These 3 Small-Cap Coronavirus Stocks
October 20, 2020The Motley Fool
Beware of Investing in These 3 Small-Cap Coronavirus Stocks
Airline coalition wants WHO to 'get rid of quarantines,' replace with testing
October 19, 2020FOX Business
Airline coalition wants WHO to 'get rid of quarantines,' replace with testing
Is Netflix about to raise prices in U.S.? Recent actions suggest it could happen
October 15, 2020MarketWatch
Is Netflix about to raise prices in U.S.? Recent actions suggest it could happen
Tesla and Netflix put their big 2020 gains on the line this week
October 17, 2020MarketWatch
Tesla and Netflix put their big 2020 gains on the line this week
‘Smart money’ just reversed bets against tech stocks in a huge way
October 18, 2020MarketWatch
‘Smart money’ just reversed bets against tech stocks in a huge way
1 in 4 U.S. workers have considered quitting due to pandemic worries
October 19, 2020MarketWatch
1 in 4 U.S. workers have considered quitting due to pandemic worries
Opinion: Better forest management means thinning trees — and will cost billions of dollars
October 14, 2020MarketWatch
Opinion: Better forest management means thinning trees — and will cost billions of dollars
Moderna CEO eyes December for COVID vaccine
October 19, 2020MarketWatch
Moderna CEO eyes December for COVID vaccine
‘I wish there were more and better protections’: Do you feel unsafe going to work because of COVID-19? Here are your options
October 20, 2020MarketWatch
‘I wish there were more and better protections’: Do you feel unsafe going to work because of COVID-19? Here are your options
Heathrow offers one-hour COVID-19 tests — they’re not cheap
October 20, 2020MarketWatch
Heathrow offers one-hour COVID-19 tests — they’re not cheap
My brother is in his mid-50s and nearly lost his home twice. Should I give him half of my inheritance to pay off his mortgage?
October 20, 2020MarketWatch
My brother is in his mid-50s and nearly lost his home twice. Should I give him half of my inheritance to pay off his mortgage?
Google targeted in antitrust suit filed Tuesday by Justice Department
October 20, 2020MarketWatch
Google targeted in antitrust suit filed Tuesday by Justice Department
Stimulus bets drive Wall Street higher
October 20, 2020Reuters
Stimulus bets drive Wall Street higher
Qualcomm jumps into 5G infrastructure market with base station chips
October 20, 2020Reuters
Qualcomm jumps into 5G infrastructure market with base station chips
Wall Street sees profit recovery for automakers, but will it last?
October 20, 2020Reuters
Wall Street sees profit recovery for automakers, but will it last?
AMC warns bankruptcy is on the table as cash runs low
October 20, 2020CNBC
AMC warns bankruptcy is on the table as cash runs low
GM to invest $2.2 billion in U.S. manufacturing to increase EV production
October 20, 2020CNBC
GM to invest $2.2 billion in U.S. manufacturing to increase EV production